Abstract:OBJECTIVE:To examine the association of preoperative carcinoembryonic antigen (CEA) level with the efficacy of neoadjuvant radiochemotherapy and postoperative metastasis and relapse in patients with rectal cancer.METHODS:Between January 2011 and January 2014, 325 patients with local advanced rectal cancer underwent preoperative radiochemotherapy and radical operation in Department of Colorectal Cancer Surgery, Beijing University Cancer Hospital, including 194 males and 131 females. According to preoperative MRI, all the patients suffered from clinical T3-4 tumors or positive lymph nodes. Their Zubrod-ECOG-WHO score was 0-1. These patients received preoperative intensity modulated radiotherapy which consisted of 50.6 Gy in 22 fractions (IMRT GTV 50.6 Gy/CTV 41.8 Gy/22 f) with capecitabine(825 mg/m2, twice per day) as radiosensitizer. According to the preoperative serum CEA level, patients were divided into high group (125 cases) and normal group (200 cases). In high group, serum CEA level decreased into normal range in 60 patients (high-normal group) after radiochemotherapy, while it was still in high level in other 65 patients (high-high group). The differences in sensitivity to radiochemotherapy and 3-year disease free survival (DFS) of these patients were both evaluated.RESULTS:In high group and normal group, the complete response rates were 18.4% (23/125) and 17.5% (35/200) (χ2=0.319, P=0.660); the percentages of tumor regression grade(TRG) 0-1 patients were 68.0%(85/125) and 67.5%(135/200)(χ2=0.009, P=0.925); the T downstage rates were 63.2%(79/125) and 70.0%(140/200)(χ2=1.266, P=0.274), respectively, whose differences were all not significant. The 3-year DFS rate in high group was 62.4%, which was significantly lower than 93.5% in normal group (χ2=53.147, P=0.000). There were 65 patients in high-high group, accounting for 52% (65/125) of high group. Among these 65 patients, 44(67.7%) presented recurrence and metastasis within 3 years and the 3-year DFS was 32.3%, which was much lower than 95.0% of 60 patients in high-normal group(χ2=182.085, P=0.000).CONCLUSIONS:Preoperative serum CEA level may not be used to predict tumor response of rectal cancer patients who receive preoperative radiochemotherapy. However, the prognosis of patients with high CEA level is worse. Recurrence and metastasis are more likely to occur in patients with high CEA level after radiochemotherapy.

Role Of Blood Tumor Markers In Predicting Metastasis And Local Recurrence After Curative Resection Of Colon Cancer

Cmar_a_246566 2767..2775

Postoperative Carcinoembryonic Antigen (CEA) Levels Predict Outcomes after Resection of Colorectal Cancer in Patients with Normal Preoperative CEA Levels.

The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I ~ III Colorectal Cancer

Prognostic Significance of Preoperative Serum Carcinoembryonic Antigen Varies with Lymph Node Metastasis Status in Colorectal Cancer

[Predictive Value of Preoperative Detection of CEA and CA199 for Prognosis in Patients with Stage II-III Colorectal Cancer].

The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients

Prognostic role of serum carcinoembryonic antigen in patients receiving liver resection for colorectal cancer liver metastasis: A meta-analysis

Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer

Prognostic value of preoperative CA199 in advanced colorectal cancer patients with normal carcinoembryonic antigen level

Prospective Evaluation of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 15.3 (CA 15.3) in Patients with Primary Locoregional Breast Cancer

[Predictive Value of Serum Carcinoembryonic Antigen Level in Efficacy and Prognosis for Patients with Rectal Cancer Following Preoperative Radiochemotherapy].

Prognostic Value of Preoperative Serum Tumor Markers in Gastric Cancer

The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer

Predictive value of preoperative routine examination for the prognosis of patients with pT2N0M0 or pT3N0M0 colorectal cancer

The Value of Blood Tumor Markers in the Prognosis of Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer before First-line Chemotherapy

Preoperative serum markers for individual patient prognosis in stage I–III colon cancer

Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer

Relationship among CEA, CA199, clinical pathological characteristics and prognosis in patients with rectal cancer

Prognostic Significance of Pretreatment Serum Carcinoembryonic Antigen Levels in Gastric Cancer with Pathological Lymph Node-Negative: A Large Sample Single-Center Retrospective Study.

The Advantage of Circulating Tumor Cells over Serum Carcinoembryonic Antigen for Predicting Treatment Responses in Rectal Cancer.